Cargando…
Elabela gene therapy promotes angiogenesis after myocardial infarction
This study was aimed at investigating whether Elabela (ELA) gene therapy can promote angiogenesis in the treatment of myocardial infarction (MI). The fusion expression plasmid pAAV‐3 × Flag/ELA‐32 was successfully constructed using molecular cloning technique. The model of acute MI was established b...
Autores principales: | Jin, Liangli, Pan, Yang, Li, Quanyi, Li, Jing, Wang, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419192/ https://www.ncbi.nlm.nih.gov/pubmed/34291565 http://dx.doi.org/10.1111/jcmm.16814 |
Ejemplares similares
-
Increased Elabela levels in the acute ST segment elevation myocardial infarction patients
por: Dönmez, Yurdaer, et al.
Publicado: (2019) -
Elabela and Apelin regulate coronary angiogenesis in a competitive manner
por: A. Madiha, Syeda, et al.
Publicado: (2023) -
Apela improves cardiac and renal function in mice with acute myocardial infarction
por: Pan, Yang, et al.
Publicado: (2020) -
Downregulation of circFASTKD1 ameliorates myocardial infarction by promoting angiogenesis
por: Gao, Wen-Qing, et al.
Publicado: (2020) -
Peptide hormone ELABELA enhances extravillous trophoblast differentiation, but placenta is not the major source of circulating ELABELA in pregnancy
por: Georgiadou, Danai, et al.
Publicado: (2019)